Company Directory / research

Aravax logo

PrivateFor profitresearchMelbourne, Australia

Aravax

Aravax is an early stage biotechnology company focused on developing the first safe and rapidly effective treatment for peanut allergy.

Founded
2015
11 years ago
Staff
11-50
band, as listed
Followers
-
on LinkedIn
Funding
$42M
as listed, currency not stated

Set against six million companies

Size

1-1011-5051-100101-250251-500501-10001k-5k5k-10k10k+

11-50 people: larger than 33% of companies with a size listed

Age

201519002026

11 years old.

Reach

Website ranked #11,510,596 in the world for traffic, about 156 visits a month.

What it does

BiotechnologyHealth CareWellness

Funding, as listed

$42M currency not stated

  • Rounds3
  • LatestSeries b, Jan 2024
  • Investors8, 3 leading

What the source datasets report. We have not watched these rounds ourselves.

FoundersRobyn O'Hehir, Sara Prickett

Every detail we hold

Everything the source datasets list about Aravax, field by field. Contact details are held but never shown.

The company

Name
Aravax
Type
For profit
Status
Private
Founded
2015
Founders
Robyn O'Hehir, Sara Prickett
Industry
research
Categories
Biotechnology, Health Care, Wellness

Where

City
Melbourne
Country
Australia
Markets
Asia-Pacific (APAC), Australasia

Size and reach

Staff band
11-50
Web traffic rank
#11,510,596
Monthly web visits
156

Funding, as listed

Total
42,200,000 (currency not stated)
Rounds
3
Latest round
Series b
Latest round date
Jan 2024
Investors
8
Lead investors
3
Listing status
private

About this record

Sources
Crunchbase
Last imported
Sept 2026

Growth, as the source summarises it

Aravax may be growing as it has successfully raised significant funds in a Series B round, securing US$68 million to advance its peanut allergy therapy. This capital injection is indicative of investor confidence and provides the financial resources necessary for further development and potential commercialization of its treatment. Additionally, the company has been involved in groundbreaking research for a peanut allergy cure, which suggests progress in its core business operations and potential for future revenue streams.

Summaries written by the source dataset, not by us, and not checked.

Companies like it

research in Australia.

See all in the directory →

From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 128,574 companies in Australia and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.